Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Gray Cameron Create: Alert

All | News | Filings
Date FiledTypeDescription
06/16/2022 4 Gray Cameron (Director) has filed a Form 4 on Cue Biopharma, Inc.
Txns: Paid exercise price by delivering 51,562 shares @ $3.2, valued at $165k
Exercised (in-or-at-the-money) 61,111 warrants @ $2.7, valued at $165k
01/05/2022 4 Gray Cameron (Director) has filed a Form 4 on Cue Biopharma, Inc.
Txns: Granted 10,000 options to buy @ $12.28, valued at $122.8k
02/01/2021 5 Form 5 - Annual statement of changes in beneficial ownership of securities:
01/06/2021 4 Gray Cameron (Director) has filed a Form 4 on Cue Biopharma, Inc.
Txns: Granted 10,000 options to buy @ $12.36, valued at $123.6k
10/01/2020 4 Gray Cameron (Director) has filed a Form 4 on Cue Biopharma, Inc.
Txns: Bought 5,000 shares @ $15, valued at $75k
Bought 5,000 shares @ $15.3, valued at $76.5k
01/06/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/28/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/03/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/26/2018 4/A Gray Cameron (Director) has filed a Form 4 on Provention Bio, Inc.
Txns: Acquired 504,668 warrants @ $5, valued at $2.5M
07/19/2018 4 Gray Cameron (Director) has filed a Form 4 on Provention Bio, Inc.
Txns: Granted 128,981 options to buy @ $4, valued at $515.9k
Converted 144,824 options to buy @ $2.5, valued at $362.1k
07/03/2018 3 Gray Cameron (Director) has filed a Form 3 on Provention Bio, Inc.
06/14/2018 4 Gray Cameron (Director) has filed a Form 4 on Cue Biopharma, Inc.
Txns: Exercised 8,000 options to buy @ $14.24, valued at $113.9k
12/27/2017 3 Gray Cameron (Director) has filed a Form 3 on Cue Biopharma, Inc.
11/01/2013 3 Gray Cameron (CEO, CFO, Secretary, Treasurer) has filed a Form 3 on ENDEAVOR IP, INC.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy